DUBLIN, Calif.--(BUSINESS WIRE)--SuperGen, Inc. (NASDAQ:SUPG), a pharmaceutical company dedicated to the discovery and development of novel cancer therapies, today announced that James S.J. Manuso, Ph.D., President and Chief Executive Officer, will present at The New York Society of Security Analysts’ 14th Biotech & Specialty Pharmaceuticals Industry Investor Conference on Tuesday, November 30th in New York.
